We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » California OTC Drugmaker Draws FDA Warning for Repeated Lapses, Unapproved Drugs
California OTC Drugmaker Draws FDA Warning for Repeated Lapses, Unapproved Drugs
The FDA issued a warning letter to over-the-counter (OTC) drug manufacturer DSP Skin Care for quality lapses at its facility in Los Angeles, Calif., noting that the company had failed to remediate issues documented during agency inspections in 2018 and 2021.